Concepedia

Zachary M. Avigan

ZM

Statistics

Publications

5

Citations

141

H-Index

5

Active since

2019

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Beth Israel Deaconess Medical Center

Harvard University

Tisch Hospital

Zachary M. Avigan is an author at Icahn School of Medicine at Mount Sinai specializing in oncology, medicine, and transplant rejection.

ORCID

Publications per year

2019–2025

5

Publications

5

Development of a 2-dimensional atlas of the human kidney with imaging mass cytometry

Nikhil Singh, Zachary M. Avigan, Judith A. Kliegel et al. · JCI Insight · 2019 · 51 citations · Full text

, , +11

Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia

Harry Fruchtman, Zachary M. Avigan, Julian A. Waksal et al. · Leukemia · 2024 · 41 citations · Full text

, , +16

Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire

Giulia Cheloni, Dimitra Karagkouni, Yered Pita-Juárez et al. · Nature Communications · 2025 · 18 citations · Full text

, , +17

Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease

Anita G. Koshy, Haesook T. Kim, Jessica Liegel et al. · Blood · 2023 · 16 citations · Full text

, , +11

Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T-cell Therapy

Zachary M. Avigan, Jerrel L. Catlett, Saoirse Bodnar et al. · Clinical Cancer Research · 2025 · 15 citations · Full text

, , +17

1–5 of 5